714 related articles for article (PubMed ID: 27532042)
1. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis.
Karunakaran D; Geoffrion M; Wei L; Gan W; Richards L; Shangari P; DeKemp EM; Beanlands RA; Perisic L; Maegdefessel L; Hedin U; Sad S; Guo L; Kolodgie FD; Virmani R; Ruddy T; Rayner KJ
Sci Adv; 2016 Jul; 2(7):e1600224. PubMed ID: 27532042
[TBL] [Abstract][Full Text] [Related]
2. Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis.
Rasheed A; Robichaud S; Nguyen MA; Geoffrion M; Wyatt H; Cottee ML; Dennison T; Pietrangelo A; Lee R; Lagace TA; Ouimet M; Rayner KJ
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1155-1167. PubMed ID: 32212851
[TBL] [Abstract][Full Text] [Related]
3. A role of RIP3-mediated macrophage necrosis in atherosclerosis development.
Lin J; Li H; Yang M; Ren J; Huang Z; Han F; Huang J; Ma J; Zhang D; Zhang Z; Wu J; Huang D; Qiao M; Jin G; Wu Q; Huang Y; Du J; Han J
Cell Rep; 2013 Jan; 3(1):200-10. PubMed ID: 23333278
[TBL] [Abstract][Full Text] [Related]
4. miR-223-3p Prevents Necroptotic Macrophage Death by Targeting Ripk3 in a Negative Feedback Loop and Consequently Ameliorates Advanced Atherosclerosis.
Jia Y; Cheng L; Yang J; Mao J; Xie Y; Yang X; Zhang X; Wang D; Zhao Z; Schober A; Wei Y
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):218-237. PubMed ID: 37970714
[TBL] [Abstract][Full Text] [Related]
5. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
Zhang L; Feng Q; Wang T
Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
[TBL] [Abstract][Full Text] [Related]
6. RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells.
Negroni A; Colantoni E; Pierdomenico M; Palone F; Costanzo M; Oliva S; Tiberti A; Cucchiara S; Stronati L
Dig Liver Dis; 2017 Nov; 49(11):1201-1210. PubMed ID: 28844856
[TBL] [Abstract][Full Text] [Related]
7. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis.
Rohde K; Kleinesudeik L; Roesler S; Löwe O; Heidler J; Schröder K; Wittig I; Dröse S; Fulda S
Cell Death Differ; 2017 Jan; 24(1):83-97. PubMed ID: 27834956
[TBL] [Abstract][Full Text] [Related]
8. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1.
Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y
Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003
[TBL] [Abstract][Full Text] [Related]
9. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis.
Wu J; Huang Z; Ren J; Zhang Z; He P; Li Y; Ma J; Chen W; Zhang Y; Zhou X; Yang Z; Wu SQ; Chen L; Han J
Cell Res; 2013 Aug; 23(8):994-1006. PubMed ID: 23835476
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages.
Kluck GEG; Qian AS; Sakarya EH; Quach H; Deng YD; Trigatti BL
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):45-63. PubMed ID: 36353992
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Necroptosis Attenuates Kidney Inflammation and Interstitial Fibrosis Induced By Unilateral Ureteral Obstruction.
Xiao X; Du C; Yan Z; Shi Y; Duan H; Ren Y
Am J Nephrol; 2017; 46(2):131-138. PubMed ID: 28723681
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotanshinone I Attenuates Plaque Vulnerability in Apolipoprotein E-Deficient Mice: Role of Receptor-Interacting Protein 3.
Zhao W; Li C; Zhang H; Zhou Q; Chen X; Han Y; Chen X
Antioxid Redox Signal; 2021 Feb; 34(5):351-363. PubMed ID: 32323566
[No Abstract] [Full Text] [Related]
13.
Karunakaran D; Nguyen MA; Geoffrion M; Vreeken D; Lister Z; Cheng HS; Otte N; Essebier P; Wyatt H; Kandiah JW; Jung R; Alenghat FJ; Mompeon A; Lee R; Pan C; Gordon E; Rasheed A; Lusis AJ; Liu P; Matic LP; Hedin U; Fish JE; Guo L; Kolodgie F; Virmani R; van Gils JM; Rayner KJ
Circulation; 2021 Jan; 143(2):163-177. PubMed ID: 33222501
[TBL] [Abstract][Full Text] [Related]
14. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitor PS-341 limits macrophage necroptosis by promoting cIAPs-mediated inhibition of RIP1 and RIP3 activation.
Zhang Y; Cheng J; Zhang J; Wu X; Chen F; Ren X; Wang Y; Li Q; Li Y
Biochem Biophys Res Commun; 2016 Sep; 477(4):761-767. PubMed ID: 27363341
[TBL] [Abstract][Full Text] [Related]
16. Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage.
Zhang Q; Wei S; Lu J; Fu W; Chen H; Huang Q; Chen Z; Zeng Z
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G551-G561. PubMed ID: 30735454
[TBL] [Abstract][Full Text] [Related]
17. HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
Park JH; Jung KH; Kim SJ; Yoon YC; Yan HH; Fang Z; Lee JE; Lim JH; Mah S; Hong S; Kim YS; Hong SS
Cancer Lett; 2019 Mar; 444():94-104. PubMed ID: 30583075
[TBL] [Abstract][Full Text] [Related]
18. RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality.
Meng L; Jin W; Wang X
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):11007-12. PubMed ID: 26283397
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ induces the cell surface exposure of phosphatidylserine by activating the protein MLKL in the absence of caspase-8 activity.
Chen J; Kuroki S; Someda M; Yonehara S
J Biol Chem; 2019 Aug; 294(32):11994-12006. PubMed ID: 31217278
[TBL] [Abstract][Full Text] [Related]
20. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
Coornaert I; Hofmans S; Devisscher L; Augustyns K; Van Der Veken P; De Meyer GRY; Martinet W
Expert Opin Drug Discov; 2018 Jun; 13(6):477-488. PubMed ID: 29598451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
